Effects of Different Types of Exercise Interventions in Patients With Type 2 Diabetes

June 22, 2011 updated by: University of Giessen

Effects of Different Types of Exercise Interventions in Patients With Type 2 Diabetes - Aerobic Endurance Training Versus Strength Endurance Training Versus Combined Aerobic Endurance and Strength Endurance Training -

The purposes of the study are

  • to determine which kind of supervised exercise intervention (aerobic endurance training versus strength endurance training versus combined aerobic endurance and strength endurance training) is more effective in improving the metabolic parameters in typ 2 diabetes patients
  • to investigate what kind of intervention is more successful in reduction of concomitant diseases and improving quality of life
  • to assess what kind of intervention induces highest effects in long term persistence of these positive changes

Study Overview

Detailed Description

Meta-analyses which evaluated the effects of structured exercise programs in patients with type 2 diabetes demonstrate that regular physical activity improves glycosylated haemoglobin (König et al.: Resistance Exercise and Type 2 Diabetes Mellitus, Deutsche Zeitschrift für Sportmedizin Jahrgang 62, Nr. 1 (2011): 5-9). Sigal et al. proved that either aerobic or resistance training alone improved glycemic control in type 2 diabetes, but the improvements are greatest with combined aerobic and resistance training (Sigal, RJ, et al.: Effects of Aerobic Training, Resistance Training, or Both on Glycemic Control in Type 2 Diabetes, Ann Intern Med. 2007 Sep 18;147(6):357-69).

Therefore, aim of the current study is to compare the effects of aerobic endurance training or resistance endurance training or the combination of aerobic endurance training and resistance endurance training in diabetes type 2 patients without any other lifestyle or dietary interventions.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hessen
      • Giessen, Hessen, Germany, 35394
        • University of Gießen
    • Sachsen
      • Zwickau, Sachsen, Germany, 08056
        • Sportpark Zwickau, Glauchau, Meerane

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • diagnoses of type 2 diabetes (ADA criteria)
  • admitted diabetes treatments will be diet and oral hypoglycemic agents

Exclusion Criteria:

  • sports intervention >60 minutes per week
  • medical conditions
  • preproliferative or proliferative retinopathy
  • instable coronary heart disease
  • inability to perform the scheduled physical activity programs
  • acute clinically significant intercurrent diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Aerobic endurance training intervention
Aerobic endurance training

The aerobic endurance training group will use cardiovascular training devices

week 1-4: 15 minutes warm up (group) 15 minutes intervention at 80-100% vAT two times per week

week 5-13: 15 minutes warm up (group) 30 minutes intervention at 95-110% vAT two times per week

week 14-26: 15 minutes warm up (group) 45 minutes intervention at 95-110% vAT two times per week

Other Names:
  • aerobic endurance training
Experimental: Strength endurance training intervention
Strength endurance training

The strength endurance training intervention group will perform eight exercises on weight machines (Milon circuit training- 60 seconds activity, 30 seconds break)

week 1-4: 15 minutes warm up (group) 1 session resistance training intensity 3 (Buskies) two times per week

week 5-13: 15 minutes warm up (group) 2 sessions resistance training intensity 5 (Buskies) two times per week

week 14-26: 15 minutes warm up (group) 3 sessions resistance training intensity 5 (Buskies) two times per week

Other Names:
  • Strength endurance training
Experimental: Combined training intervention
Combined aerobic endurance training and strength endurance training intervention

week 1-4: 15 minutes warm up (group) 15 minutes intervention at 80-100% vAT once per week and 15 minutes warm up (group) 1 session resistance training intensity 3 (Buskies) once per week

week 5-13: 15 minutes warm up (group) 15 minutes intervention at 95-110% vAT and 1 session resistance training intensity 5 (Buskies) two times per week

week 14-26: 15 minutes warm up (group) 30 minutes intervention at 95-110% vAT and 1 session resistance training intensity 5 (Buskies) once a week and 15 minutes warm up (group) 15 minutes intervention at 95-110% vAT and 2 sessions resistance training intensity 5 (Buskies) once a week

No Intervention: Control group
control group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in HbA1c-level (haemoglobin A1c)
Time Frame: 6 months
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in HOMA-Index
Time Frame: 3 and 6 months
3 and 6 months
Change in beta-cell-function
Time Frame: 3 and 6 months
Measured by OGTT (Oral Glucose Tolerance Test)
3 and 6 months
Change in fasting plasma glucose levels
Time Frame: 3 and 6 months
3 and 6 months
Change in total cholesterol levels
Time Frame: 3 and 6 months
3 and 6 months
Change in HDL-cholesterol levels
Time Frame: 3 and 6 months
3 and 6 months
Change in LDL-cholesterol levels
Time Frame: 3 and 6 months
3 and 6 months
Change in triglyceride levels
Time Frame: 3 and 6 months
3 and 6 months
Change in antidiabetic medications
Time Frame: 3 and 6 months
Class and dosage of blood-glucose lowering drugs are recorded before, after 3 and 6 months
3 and 6 months
Change in inflammation markers
Time Frame: 3 and 6 months
CrP, blood count, interleukinstatus, cytokinstatus
3 and 6 months
Change in body weight
Time Frame: 3 and 6 months
3 and 6 months
Change in body composition
Time Frame: 3 and 6 months
by Bio-impedance analysis, waist to hip ratio, range of thigh
3 and 6 months
Change in strength
Time Frame: 3 and 6 months
by Dr. Wolff Back Check
3 and 6 months
Change of maximum heart rate
Time Frame: 3 and 6 months
Measured by an incremental exercise test
3 and 6 months
Change of peak oxygen uptake
Time Frame: 3 and 6 months
Measured by an incremental exercise test
3 and 6 months
Change of vAT (ventilatory anaerobic threshold)
Time Frame: 3 and 6 months
Measured by an incremental exercise test
3 and 6 months
Change in blood pressure
Time Frame: 3 and 6 months
3 and 6 months
Change in renal function
Time Frame: 3 and 6 months
Creatininlevel, Albuminlevel (urine), Telomere length
3 and 6 months
Change in concentration
Time Frame: 3 and 6 months
by d2-test
3 and 6 months
Change in quality of life
Time Frame: 3 and 6 months
by questionnaire: SF-12, EQ5
3 and 6 months
Change of nutrition
Time Frame: 3 and 6 months
by questionnaire: FEV, FFQ
3 and 6 months
Change in voluntary physical activity
Time Frame: 3 and 6 months
meassured by pedometer (one week)
3 and 6 months
Change of cardiac output by Impedance cardiography
Time Frame: 3 and 6 months
by Task Force Monitor
3 and 6 months
Change of barorezeptorsensitivity
Time Frame: 3 and 6 months
by Task Force Monitor
3 and 6 months
Change in carotid-Intima-Media-Thickness
Time Frame: 3 and 6 months
3 and 6 months
Change in aortic pulse-wave velocity
Time Frame: 3 and 6 months
3 and 6 months
Change in central aortic pressure
Time Frame: 3 and 6 month
3 and 6 month
Change in endothelial dysfunction
Time Frame: 3 and 6 months
3 and 6 months
Change of parodontitis
Time Frame: 3 and 6 months
3 and 6 months
Follow up of all parameters mentioned above
Time Frame: after 12 months
Follow up after 12 months (6 months after completing the exercise intervention) without any supervised intervention
after 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Andree Hillebrecht, Dr. med., University of Gießen

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2011

Primary Completion (Anticipated)

November 1, 2011

Study Completion (Anticipated)

June 1, 2012

Study Registration Dates

First Submitted

June 9, 2011

First Submitted That Met QC Criteria

June 20, 2011

First Posted (Estimate)

June 21, 2011

Study Record Updates

Last Update Posted (Estimate)

June 23, 2011

Last Update Submitted That Met QC Criteria

June 22, 2011

Last Verified

April 1, 2011

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 2 Diabetes

Clinical Trials on Aerobic endurance training intervention

3
Subscribe